ReP USP - Resultado da busca

Artigo de periodico
DYRK1A inhibitors and perspectives for the treatment of Alzheimer's disease (2023)
Souza, Márcia Maria de; Cenci, Arthur Ribeiro; Teixeira, Kerolain Faoro; Machado, Valkiria; Mendes, Majory Christina Garcia; Gonçalves, Ana Elisa; Dalmagro, Ana Paula; Cazarin, Camila André; Ferreira, Leonardo Luiz Gomes ; Oliveira, Aldo Sena de ; Andricopulo, Adriano Defini
Source: Current Medicinal Chemistry. Unidade: IFSC
Subjects: DOENÇA DE ALZHEIMER, INIBIDORES DE ENZIMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Márcia Maria de et al. DYRK1A inhibitors and perspectives for the treatment of Alzheimer's disease. Current Medicinal Chemistry, v. 30, n. 6, p. 669-688, 2023Tradução . . Disponível em: https://doi.org/10.2174/0929867329666220620162018. Acesso em: 13 nov. 2024.
APA
Souza, M. M. de, Cenci, A. R., Teixeira, K. F., Machado, V., Mendes, M. C. G., Gonçalves, A. E., et al. (2023). DYRK1A inhibitors and perspectives for the treatment of Alzheimer's disease. Current Medicinal Chemistry, 30( 6), 669-688. doi:10.2174/0929867329666220620162018
NLM
Souza MM de, Cenci AR, Teixeira KF, Machado V, Mendes MCG, Gonçalves AE, Dalmagro AP, Cazarin CA, Ferreira LLG, Oliveira AS de, Andricopulo AD. DYRK1A inhibitors and perspectives for the treatment of Alzheimer's disease [Internet]. Current Medicinal Chemistry. 2023 ; 30( 6): 669-688.[citado 2024 nov. 13 ] Available from: https://doi.org/10.2174/0929867329666220620162018
Vancouver
Souza MM de, Cenci AR, Teixeira KF, Machado V, Mendes MCG, Gonçalves AE, Dalmagro AP, Cazarin CA, Ferreira LLG, Oliveira AS de, Andricopulo AD. DYRK1A inhibitors and perspectives for the treatment of Alzheimer's disease [Internet]. Current Medicinal Chemistry. 2023 ; 30( 6): 669-688.[citado 2024 nov. 13 ] Available from: https://doi.org/10.2174/0929867329666220620162018
Artigo de periodico
Design of novel phosphopantetheine adenylyltransferase inhibitors: a potential new approach to tackle Mycobacterium tuberculosis (2021)
Primi, Marina Candido ; Tavares, Maurício Temotheo ; Klein, Larry L; Izard, Tina; Sant'Anna, Carlos M. R; Franzblau, Scott Gary; Ferreira, Elizabeth Igne
Source: Current Topics in Medicinal Chemistry. Unidade: FCF
Subjects: TUBERCULOSE, ANTIBIÓTICOS, INIBIDORES DE ENZIMAS, QUIMIOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PRIMI, Marina Candido et al. Design of novel phosphopantetheine adenylyltransferase inhibitors: a potential new approach to tackle Mycobacterium tuberculosis. Current Topics in Medicinal Chemistry, v. 21, p. 1186-1197, 2021Tradução . . Disponível em: https://doi.org/10.2174/1568026621666210728094804. Acesso em: 13 nov. 2024.
APA
Primi, M. C., Tavares, M. T., Klein, L. L., Izard, T., Sant'Anna, C. M. R., Franzblau, S. G., & Ferreira, E. I. (2021). Design of novel phosphopantetheine adenylyltransferase inhibitors: a potential new approach to tackle Mycobacterium tuberculosis. Current Topics in Medicinal Chemistry, 21, 1186-1197. doi:10.2174/1568026621666210728094804
NLM
Primi MC, Tavares MT, Klein LL, Izard T, Sant'Anna CMR, Franzblau SG, Ferreira EI. Design of novel phosphopantetheine adenylyltransferase inhibitors: a potential new approach to tackle Mycobacterium tuberculosis [Internet]. Current Topics in Medicinal Chemistry. 2021 ; 21 1186-1197.[citado 2024 nov. 13 ] Available from: https://doi.org/10.2174/1568026621666210728094804
Vancouver
Primi MC, Tavares MT, Klein LL, Izard T, Sant'Anna CMR, Franzblau SG, Ferreira EI. Design of novel phosphopantetheine adenylyltransferase inhibitors: a potential new approach to tackle Mycobacterium tuberculosis [Internet]. Current Topics in Medicinal Chemistry. 2021 ; 21 1186-1197.[citado 2024 nov. 13 ] Available from: https://doi.org/10.2174/1568026621666210728094804
Artigo de periodico
Proposition of potential GSK-3β inhibitors for the treatment of Alzheimer’s disease: a molecular modeling study (2020)
Castro, Leandro L.; Picanço, Leide C. S.; Silva, Jaderson V.; Souza, Lucilene R.; Sousa, Kessia P. A.; Pinheiro, Abraão A.; Chaves, Gisele A.; Teixeira, Hueldem R. C.; Silva, Guilherme Martins da ; Taft, Carlton A.; Silva, Carlos Henrique Tomich de Paula da ; Melim, Lorane Izabel da Silva Hage
Source: Current Computer-Aided Drug Design. Unidades: FCFRP, FFCLRP
Subjects: DOENÇA DE ALZHEIMER, MODELAGEM MOLECULAR, PLANEJAMENTO DE FÁRMACOS, INIBIDORES DE ENZIMAS, FARMACOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CASTRO, Leandro L. et al. Proposition of potential GSK-3β inhibitors for the treatment of Alzheimer’s disease: a molecular modeling study. Current Computer-Aided Drug Design, v. 16, n. 5, p. 541-554, 2020Tradução . . Disponível em: https://doi.org/10.2174/1573409915666191015110734. Acesso em: 13 nov. 2024.
APA
Castro, L. L., Picanço, L. C. S., Silva, J. V., Souza, L. R., Sousa, K. P. A., Pinheiro, A. A., et al. (2020). Proposition of potential GSK-3β inhibitors for the treatment of Alzheimer’s disease: a molecular modeling study. Current Computer-Aided Drug Design, 16( 5), 541-554. doi:10.2174/1573409915666191015110734
NLM
Castro LL, Picanço LCS, Silva JV, Souza LR, Sousa KPA, Pinheiro AA, Chaves GA, Teixeira HRC, Silva GM da, Taft CA, Silva CHT de P da, Melim LI da SH. Proposition of potential GSK-3β inhibitors for the treatment of Alzheimer’s disease: a molecular modeling study [Internet]. Current Computer-Aided Drug Design. 2020 ; 16( 5): 541-554.[citado 2024 nov. 13 ] Available from: https://doi.org/10.2174/1573409915666191015110734
Vancouver
Castro LL, Picanço LCS, Silva JV, Souza LR, Sousa KPA, Pinheiro AA, Chaves GA, Teixeira HRC, Silva GM da, Taft CA, Silva CHT de P da, Melim LI da SH. Proposition of potential GSK-3β inhibitors for the treatment of Alzheimer’s disease: a molecular modeling study [Internet]. Current Computer-Aided Drug Design. 2020 ; 16( 5): 541-554.[citado 2024 nov. 13 ] Available from: https://doi.org/10.2174/1573409915666191015110734
Artigo de periodico
Kinetic and crystallographic studies on glyceraldehyde-3-phosphate dehydrogenase from Trypanosoma cruzi in complex with iodoacetate (2009)
Guido, Rafael Victorio Carvalho ; Balliano, Tatiane L.; Andricopulo, Adriano Defini ; Oliva, Glaucius
Source: Letters in Drug Design and Discovery. Unidade: IFSC
Subjects: PLANEJAMENTO DE FÁRMACOS, INIBIDORES DE ENZIMAS, TRYPANOSOMA CRUZI (ESTUDO), ENZIMAS, INFECÇÕES POR PROTOZOÁRIOS, CRISTALOGRAFIA DE RAIOS X
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUIDO, Rafael Victorio Carvalho et al. Kinetic and crystallographic studies on glyceraldehyde-3-phosphate dehydrogenase from Trypanosoma cruzi in complex with iodoacetate. Letters in Drug Design and Discovery, v. 6, n. 3, p. 210-214, 2009Tradução . . Disponível em: https://doi.org/10.2174/157018009787847774. Acesso em: 13 nov. 2024.
APA
Guido, R. V. C., Balliano, T. L., Andricopulo, A. D., & Oliva, G. (2009). Kinetic and crystallographic studies on glyceraldehyde-3-phosphate dehydrogenase from Trypanosoma cruzi in complex with iodoacetate. Letters in Drug Design and Discovery, 6( 3), 210-214. doi:10.2174/157018009787847774
NLM
Guido RVC, Balliano TL, Andricopulo AD, Oliva G. Kinetic and crystallographic studies on glyceraldehyde-3-phosphate dehydrogenase from Trypanosoma cruzi in complex with iodoacetate [Internet]. Letters in Drug Design and Discovery. 2009 ; 6( 3): 210-214.[citado 2024 nov. 13 ] Available from: https://doi.org/10.2174/157018009787847774
Vancouver
Guido RVC, Balliano TL, Andricopulo AD, Oliva G. Kinetic and crystallographic studies on glyceraldehyde-3-phosphate dehydrogenase from Trypanosoma cruzi in complex with iodoacetate [Internet]. Letters in Drug Design and Discovery. 2009 ; 6( 3): 210-214.[citado 2024 nov. 13 ] Available from: https://doi.org/10.2174/157018009787847774
Artigo de periodico
Hologram quantitative structure-activity relationships for a class of inhibitors of HIV-1 protease (2007)
Ferreira, Leonardo Luiz Gomes ; Leitão, Andrei ; Montanari, Carlos Alberto ; Andricopulo, Adriano Defini
Source: Letters in Drug Design and Discovery. Unidades: IQSC, IFSC
Subjects: HIV, SÍNDROME DE IMUNODEFICIÊNCIA ADQUIRIDA, INIBIDORES DE ENZIMAS, RELAÇÕES QUANTITATIVAS ENTRE ESTRUTURA QUÍMICA E ATIVIDADE BIOLÓGICA, HOLOGRAMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Leonardo Luiz Gomes et al. Hologram quantitative structure-activity relationships for a class of inhibitors of HIV-1 protease. Letters in Drug Design and Discovery, v. 4, n. 5, p. 356-364, 2007Tradução . . Acesso em: 13 nov. 2024.
APA
Ferreira, L. L. G., Leitão, A., Montanari, C. A., & Andricopulo, A. D. (2007). Hologram quantitative structure-activity relationships for a class of inhibitors of HIV-1 protease. Letters in Drug Design and Discovery, 4( 5), 356-364.
NLM
Ferreira LLG, Leitão A, Montanari CA, Andricopulo AD. Hologram quantitative structure-activity relationships for a class of inhibitors of HIV-1 protease. Letters in Drug Design and Discovery. 2007 ; 4( 5): 356-364.[citado 2024 nov. 13 ]
Vancouver
Ferreira LLG, Leitão A, Montanari CA, Andricopulo AD. Hologram quantitative structure-activity relationships for a class of inhibitors of HIV-1 protease. Letters in Drug Design and Discovery. 2007 ; 4( 5): 356-364.[citado 2024 nov. 13 ]
Artigo de periodico
Classical and hologram QSAR studies on a series of tacrine derivatives as butyrylcholinesterase inhibitors (2007)
Castilho, M. S.; Guido, Rafael Victorio Carvalho ; Andricopulo, Adriano Defini
Source: Letters in Drug Design and Discovery. Unidade: IFSC
Subjects: DOENÇA DE ALZHEIMER, INIBIDORES DE ENZIMAS, HOLOGRAMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CASTILHO, M. S. e GUIDO, Rafael Victorio Carvalho e ANDRICOPULO, Adriano Defini. Classical and hologram QSAR studies on a series of tacrine derivatives as butyrylcholinesterase inhibitors. Letters in Drug Design and Discovery, v. 4, n. 2, p. 106-113, 2007Tradução . . Disponível em: https://doi.org/10.2174/157018007779422505. Acesso em: 13 nov. 2024.
APA
Castilho, M. S., Guido, R. V. C., & Andricopulo, A. D. (2007). Classical and hologram QSAR studies on a series of tacrine derivatives as butyrylcholinesterase inhibitors. Letters in Drug Design and Discovery, 4( 2), 106-113. doi:10.2174/157018007779422505
NLM
Castilho MS, Guido RVC, Andricopulo AD. Classical and hologram QSAR studies on a series of tacrine derivatives as butyrylcholinesterase inhibitors [Internet]. Letters in Drug Design and Discovery. 2007 ; 4( 2): 106-113.[citado 2024 nov. 13 ] Available from: https://doi.org/10.2174/157018007779422505
Vancouver
Castilho MS, Guido RVC, Andricopulo AD. Classical and hologram QSAR studies on a series of tacrine derivatives as butyrylcholinesterase inhibitors [Internet]. Letters in Drug Design and Discovery. 2007 ; 4( 2): 106-113.[citado 2024 nov. 13 ] Available from: https://doi.org/10.2174/157018007779422505

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Indexado em

Non normalized affiliation